rs1019731
| Orientation | minus | 
| Stabilized | minus | 
| Make rs1019731(G;G) | 
| Make rs1019731(G;T) | 
| Make rs1019731(T;T) | 
| Reference | GRCh38 38.1/142 | 
| Chromosome | 12 | 
| Position | 102470647 | 
| Gene | IGF1 | 
| is a | snp | 
| is | mentioned by | 
| dbSNP | rs1019731 | 
| dbSNP (classic) | rs1019731 | 
| ClinGen | rs1019731 | 
| ebi | rs1019731 | 
| HLI | rs1019731 | 
| Exac | rs1019731 | 
| Gnomad | rs1019731 | 
| Varsome | rs1019731 | 
| LitVar | rs1019731 | 
| Map | rs1019731 | 
| PheGenI | rs1019731 | 
| Biobank | rs1019731 | 
| 1000 genomes | rs1019731 | 
| hgdp | rs1019731 | 
| ensembl | rs1019731 | 
| geneview | rs1019731 | 
| scholar | rs1019731 | 
| rs1019731 | |
| pharmgkb | rs1019731 | 
| gwascentral | rs1019731 | 
| openSNP | rs1019731 | 
| 23andMe | rs1019731 | 
| SNPshot | rs1019731 | 
| SNPdbe | rs1019731 | 
| MSV3d | rs1019731 | 
| GWAS Ctlg | rs1019731 | 
| GMAF | 0.08127 | 
| Max Magnitude | 0 | 
| ? | (G;G) (G;T) (T;T) | 28 | 
|---|---|---|
| 
 
 
  | ||
[PMID 19858071
] Common Genetic Variation in IGF1, IGFBP1, and IGFBP3 and Ovarian Cancer Risk
[PMID 17300730
] Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.
[PMID 18596909
] IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
[PMID 18772892
] Can genes for mammographic density inform cancer aetiology?
[PMID 19124510
] Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.
[PMID 19207031] Growth hormone dose in growth hormone-deficient adults is not associated with IGF-1 gene polymorphisms.
[PMID 19240240
] IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.
[PMID 19551864
] Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
[PMID 21113804] IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer.
